BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 31214759)

  • 1. In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds.
    Morroni G; Simonetti O; Brenciani A; Brescini L; Kamysz W; Kamysz E; Neubauer D; Caffarini M; Orciani M; Giovanetti E; Offidani A; Giacometti A; Cirioni O
    Med Microbiol Immunol; 2019 Dec; 208(6):877-883. PubMed ID: 31214759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
    Farzi N; Oloomi M; Bahramali G; Siadat SD; Bouzari S
    Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant
    Jayathilaka EHTT; Rajapaksha DC; Nikapitiya C; De Zoysa M; Whang I
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069596
    [No Abstract]   [Full Text] [Related]  

  • 4. The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii.
    Feng X; Sambanthamoorthy K; Palys T; Paranavitana C
    Peptides; 2013 Nov; 49():131-7. PubMed ID: 24071034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of levofloxacin in combination with colistin against Acinetobacter baumannii: In vitro and in a Galleria mellonella model.
    Wei W; Yang H; Hu L; Ye Y; Li J
    J Microbiol Immunol Infect; 2017 Dec; 50(6):821-830. PubMed ID: 26725481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of Eucalyptus camaldulensis essential oils and their interactions with conventional antimicrobial agents against multi-drug resistant Acinetobacter baumannii.
    Knezevic P; Aleksic V; Simin N; Svircev E; Petrovic A; Mimica-Dukic N
    J Ethnopharmacol; 2016 Feb; 178():125-36. PubMed ID: 26671210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains.
    Gopal R; Kim YG; Lee JH; Lee SK; Chae JD; Son BK; Seo CH; Park Y
    Antimicrob Agents Chemother; 2014; 58(3):1622-9. PubMed ID: 24366740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory effect of the combination of two new peptides on biofilm formation by Acinetobacter baumannii.
    Irani N; Basardeh E; Samiee F; Fateh A; Shooraj F; Rahimi A; Shahcheraghi F; Vaziri F; Masoumi M; Pazhouhandeh M; Siadat SD; Kazemi-Lomedasht F; Jamnani FR
    Microb Pathog; 2018 Aug; 121():310-317. PubMed ID: 29859290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic and phenotypic studies of bicarinalin, BP100 and colistin action on Acinetobacter baumannii.
    Eales MG; Ferrari E; Goddard AD; Lancaster L; Sanderson P; Miller C
    Res Microbiol; 2018; 169(6):296-302. PubMed ID: 29751064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
    Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
    Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergism of colistin in combination with N-acetylcysteine against Acinetobacter baumannii grown in planktonic phase and in biofilms.
    Pollini S; Boncompagni S; Di Maggio T; Di Pilato V; Spanu T; Fiori B; Blasi F; Aliberti S; Sergio F; Rossolini GM; Pallecchi L
    J Antimicrob Chemother; 2018 Sep; 73(9):2388-2395. PubMed ID: 29846610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.
    Bardbari AM; Arabestani MR; Karami M; Keramat F; Aghazadeh H; Alikhani MY; Bagheri KP
    Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):443-454. PubMed ID: 29353377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.
    Galani I; Orlandou K; Moraitou H; Petrikkos G; Souli M
    Int J Antimicrob Agents; 2014 Apr; 43(4):370-4. PubMed ID: 24560919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the Antimicrobial Activity of
    Fleeman R; Van Horn KS; Barber MM; Burda WN; Flanigan DL; Manetsch R; Shaw LN
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sub-MIC effects of a proline-rich antibacterial peptide on clinical isolates of Acinetobacter baumannii.
    Dolzani L; Milan A; Scocchi M; Lagatolla C; Bressan R; Benincasa M
    J Med Microbiol; 2019 Aug; 68(8):1253-1265. PubMed ID: 31215857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiofilm and antimicrobial efficacy of DispersinB®-KSL-W peptide-based wound gel against chronic wound infection associated bacteria.
    Gawande PV; Leung KP; Madhyastha S
    Curr Microbiol; 2014 May; 68(5):635-41. PubMed ID: 24445333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii.
    Rodríguez-Hernández MJ; Saugar J; Docobo-Pérez F; de la Torre BG; Pachón-Ibáñez ME; García-Curiel A; Fernández-Cuenca F; Andreu D; Rivas L; Pachón J
    J Antimicrob Chemother; 2006 Jul; 58(1):95-100. PubMed ID: 16636085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.